Catharus ustulatus isolate bCatUst1 chromosome 12, bCatUst1.pri.v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Turdidae; Catharus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM020347.1.\nAssembly name: bCatUst1.pri.v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2020/12/22. The original whole-genome shotgun project has the\naccession WNMQ00000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 06-AUG-2020\nAssembly Method :: FALCON v. DX 1.9.0; FALCON-Unzip v.\n 6.0.0.47841; purge_dups github v.\n purge_haplotig (bitbucket v1.0.3+\n 1.Nov.2018); Scaff10x v. 2; Bionano Solve\n v. 3.2.1_04122018; Salsa2 HiC v. 2.2;\n Arrow polishing and gap filling v.\n Smrtlink_6.0.0.47841; Longranger Align v.\n 2.2.2; freebayes v. 1.3.1; gEVAL manual\n curation v. 2020-08-06; VGP assembly\n pipeline v. 1.5\nAssembly Name :: bCatUst1.pri.v2\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 60.58x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Catharus ustulatus Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC117001738, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC117001738, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger and SCAN domain-containing protein 30-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
leucine-rich repeat LGI family member 4-like, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
leucine-rich repeat LGI family member 4-like, transcript variant X2
leucine-rich repeat LGI family member 4-like, transcript variant X3
leucine-rich repeat LGI family member 4-like, transcript variant X4
leucine-rich repeat LGI family member 4-like isoform X1
leucine-rich repeat LGI family member 4-like isoform X2
leucine-rich repeat LGI family member 4-like isoform X3
leucine-rich repeat LGI family member 4-like isoform X4
FXYD domain-containing ion transport regulator 3-like, transcript variant X2
FXYD domain-containing ion transport regulator 3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
FXYD domain-containing ion transport regulator 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC117002246 isoform X2
uncharacterized protein LOC117002246 isoform X4
uncharacterized protein LOC117002246 isoform X1
FXYD domain-containing ion transport regulator 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC117002246 isoform X3
FXYD domain-containing ion transport regulator 3-like, transcript variant X5
uncharacterized protein LOC117002246 isoform X5
FXYD domain-containing ion transport regulator 3-like, transcript variant X6
FXYD domain-containing ion transport regulator 3-like isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117002249, transcript variant X2
uncharacterized LOC117002249, transcript variant X1
zinc finger protein 239-like, transcript variant X2
zinc finger protein 239-like, transcript variant X1
zinc finger protein 239-like, transcript variant X3
uncharacterized LOC117002248, transcript variant X1
uncharacterized LOC117002248, transcript variant X3
uncharacterized LOC117002248, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 418-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 128 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin specific peptidase 3, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 3 isoform X1
ubiquitin specific peptidase 3, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 3 isoform X2
F-box and leucine rich repeat protein 22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1, transcript variant X4
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1, transcript variant X7
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1, transcript variant X6
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1, transcript variant X3
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1, transcript variant X2
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1, transcript variant X5
HECT and RLD domain containing E3 ubiquitin protein ligase family member 1, transcript variant X1
probable E3 ubiquitin-protein ligase HERC1 isoform X4
probable E3 ubiquitin-protein ligase HERC1 isoform X7
probable E3 ubiquitin-protein ligase HERC1 isoform X6
probable E3 ubiquitin-protein ligase HERC1 isoform X3
probable E3 ubiquitin-protein ligase HERC1 isoform X2
probable E3 ubiquitin-protein ligase HERC1 isoform X5
probable E3 ubiquitin-protein ligase HERC1 isoform X1
death associated protein kinase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
death-associated protein kinase 2 isoform X2
death associated protein kinase 2, transcript variant X1
death associated protein kinase 2, transcript variant X2
death-associated protein kinase 2 isoform X1
TBC1 domain family member 2B, transcript variant X4
TBC1 domain family member 2B, transcript variant X3
TBC1 domain family member 2B, transcript variant X1
TBC1 domain family member 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
calcium and integrin binding family member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium and integrin binding family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium and integrin binding family member 2, transcript variant X3
calcium and integrin binding family member 2, transcript variant X1
calcium and integrin-binding family member 2
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial
acyl-CoA synthetase bubblegum family member 1, transcript variant X2
acyl-CoA synthetase bubblegum family member 1, transcript variant X1
long-chain-fatty-acid--CoA ligase ACSBG1 isoform X2
long-chain-fatty-acid--CoA ligase ACSBG1 isoform X1
DnaJ heat shock protein family (Hsp40) member A4
WD repeat domain 61, transcript variant X3
WD repeat domain 61, transcript variant X1
WD repeat domain 61, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 12 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
WD repeat-containing protein 61 isoform X1
WD repeat-containing protein 61 isoform X3
WD repeat-containing protein 61 isoform X2
cellular retinoic acid binding protein 1
cellular retinoic acid-binding protein 1
iron responsive element binding protein 2
iron-responsive element-binding protein 2
hydroxylysine kinase, transcript variant X2
hydroxylysine kinase, transcript variant X1
hydroxylysine kinase, transcript variant X3
cholinergic receptor nicotinic alpha 5 subunit, transcript variant X1
neuronal acetylcholine receptor subunit alpha-5 isoform X1
cholinergic receptor nicotinic alpha 5 subunit, transcript variant X2
neuronal acetylcholine receptor subunit alpha-5 isoform X2
cholinergic receptor nicotinic alpha 3 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
neuronal acetylcholine receptor subunit alpha-3
cholinergic receptor nicotinic beta 4 subunit, transcript variant X2
cholinergic receptor nicotinic beta 4 subunit, transcript variant X1
neuronal acetylcholine receptor subunit beta-4 isoform X2
neuronal acetylcholine receptor subunit beta-4 isoform X1
uncharacterized LOC117001949, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117001949, transcript variant X1
uncharacterized LOC117001949, transcript variant X2
uncharacterized LOC117001949, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117001722, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC117001722, transcript variant X2
uncharacterized LOC117001722, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
pro-neuregulin-4, membrane-bound isoform
transmembrane protein 266, transcript variant X2
transmembrane protein 266, transcript variant X1
transmembrane protein 266, transcript variant X3
electron transfer flavoprotein subunit alpha
electron transfer flavoprotein subunit alpha, mitochondrial
S-phase cyclin A associated protein in the ER, transcript variant X2
S-phase cyclin A associated protein in the ER, transcript variant X1
S phase cyclin A-associated protein in the endoplasmic reticulum
proline-serine-threonine phosphatase interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
proline-serine-threonine phosphatase-interacting protein 1 isoform X1
proline-serine-threonine phosphatase interacting protein 1, transcript variant X2
proline-serine-threonine phosphatase-interacting protein 1 isoform X2
pseudopodium enriched atypical kinase 1, transcript variant X1
pseudopodium enriched atypical kinase 1, transcript variant X9
pseudopodium enriched atypical kinase 1, transcript variant X5
pseudopodium enriched atypical kinase 1, transcript variant X4
pseudopodium enriched atypical kinase 1, transcript variant X2
pseudopodium enriched atypical kinase 1, transcript variant X6
pseudopodium enriched atypical kinase 1, transcript variant X3
pseudopodium enriched atypical kinase 1, transcript variant X8
pseudopodium enriched atypical kinase 1, transcript variant X7
inactive tyrosine-protein kinase PEAK1 isoform X2
inactive tyrosine-protein kinase PEAK1 isoform X1
high mobility group 20A, transcript variant X2
high mobility group 20A, transcript variant X4
high mobility group 20A, transcript variant X1
high mobility group 20A, transcript variant X3
high mobility group 20A, transcript variant X5
leucine rich repeat and Ig domain containing 1, transcript variant X3
leucine rich repeat and Ig domain containing 1, transcript variant X2
leucine rich repeat and Ig domain containing 1, transcript variant X1
leucine rich repeat and Ig domain containing 1, transcript variant X4
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 isoform X1
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 isoform X2
leucine rich repeat and Ig domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase non-receptor type 9, transcript variant X2
tyrosine-protein phosphatase non-receptor type 9 isoform X2
protein tyrosine phosphatase non-receptor type 9, transcript variant X3
tyrosine-protein phosphatase non-receptor type 9 isoform X3
protein tyrosine phosphatase non-receptor type 9, transcript variant X1
tyrosine-protein phosphatase non-receptor type 9 isoform X1
SIN3 transcription regulator family member A, transcript variant X2
SIN3 transcription regulator family member A, transcript variant X1
SIN3 transcription regulator family member A, transcript variant X3
mannosidase alpha class 2C member 1, transcript variant X1
mannosidase alpha class 2C member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
nei like DNA glycosylase 1, transcript variant X1
nei like DNA glycosylase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
nei like DNA glycosylase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
nei like DNA glycosylase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
chromosome 12 C15orf39 homolog, transcript variant X3
chromosome 12 C15orf39 homolog, transcript variant X1
chromosome 12 C15orf39 homolog, transcript variant X4
chromosome 12 C15orf39 homolog, transcript variant X2
chromosome 12 C15orf39 homolog, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein C15orf39 homolog isoform X1
chromosome 12 C15orf39 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
chromosome 12 C15orf39 homolog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chromosome 12 C15orf39 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein C15orf39 homolog isoform X2
uncharacterized protein C15orf39 homolog isoform X3
phosphopantothenoylcysteine decarboxylase, transcript variant X1
phosphopantothenoylcysteine decarboxylase isoform X1
phosphopantothenoylcysteine decarboxylase, transcript variant X2
phosphopantothenoylcysteine decarboxylase isoform X2
secretory carrier membrane protein 5, transcript variant X1
secretory carrier membrane protein 5, transcript variant X2
secretory carrier-associated membrane protein 5
ribonuclease P and MRP subunit p25, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ribonuclease P and MRP subunit p25, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ribonuclease P and MRP subunit p25, transcript variant X1
ribonuclease P protein subunit p25 isoform X2
ribonuclease P protein subunit p25 isoform X3
ribonuclease P protein subunit p25 isoform X1
zinc finger and SCAN domain containing 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger and SCAN domain-containing protein 2
U1 small nuclear ribonucleoprotein A-like, transcript variant X1
U1 small nuclear ribonucleoprotein A-like, transcript variant X2
U1 small nuclear ribonucleoprotein A-like
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mitotic-spindle organizing protein 2-like
Src homology 2 domain containing F, transcript variant X1
Src homology 2 domain containing F, transcript variant X2
Src homology 2 domain containing F, transcript variant X4
Src homology 2 domain containing F, transcript variant X6
Src homology 2 domain containing F, transcript variant X5
SH2 domain-containing adapter protein F isoform X1
SH2 domain-containing adapter protein F isoform X2
SH2 domain-containing adapter protein F isoform X4
Src homology 2 domain containing F, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
SH2 domain-containing adapter protein F isoform X3
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X1
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like, transcript variant X3
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like isoform X1
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like isoform X2
mucosa-associated lymphoid tissue lymphoma translocation protein 1-like isoform X3
SEC11 homolog A, signal peptidase complex subunit, transcript variant X1
SEC11 homolog A, signal peptidase complex subunit, transcript variant X2
signal peptidase complex catalytic subunit SEC11A isoform X1
signal peptidase complex catalytic subunit SEC11A isoform X2
dual oxidase maturation factor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dual oxidase maturation factor 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dual oxidase maturation factor 1-like isoform X1
dual oxidase maturation factor 1-like, transcript variant X2
dual oxidase maturation factor 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RNA binding protein, mRNA processing factor 2, transcript variant X1
RNA-binding protein with multiple splicing 2 isoform X1
RNA binding protein, mRNA processing factor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RNA-binding protein with multiple splicing 2 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ornithine decarboxylase antizyme 2
zinc finger protein 609, transcript variant X1
zinc finger protein 609, transcript variant X2
zinc finger protein 609, transcript variant X3
thyroid hormone receptor interactor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
thyroid hormone receptor interactor 4, transcript variant X3
activating signal cointegrator 1 isoform X2
thyroid hormone receptor interactor 4, transcript variant X1
activating signal cointegrator 1 isoform X1
casein kinase 1 gamma 1, transcript variant X1
casein kinase 1 gamma 1, transcript variant X5
casein kinase 1 gamma 1, transcript variant X3
casein kinase 1 gamma 1, transcript variant X2
casein kinase 1 gamma 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
LOW QUALITY PROTEIN: protein PAT1 homolog 2
telomere repeat binding bouquet formation protein 2, transcript variant X2
telomere repeats-binding bouquet formation protein 2 isoform X2
telomere repeat binding bouquet formation protein 2, transcript variant X1
telomere repeats-binding bouquet formation protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00056
cytoplasmic polyadenylation element binding protein 1, transcript variant X2
cytoplasmic polyadenylation element binding protein 1, transcript variant X3
cytoplasmic polyadenylation element binding protein 1, transcript variant X1
cytoplasmic polyadenylation element binding protein 1, transcript variant X5
cytoplasmic polyadenylation element binding protein 1, transcript variant X4
cytoplasmic polyadenylation element binding protein 1, transcript variant X6
cytoplasmic polyadenylation element-binding protein 1 isoform X3
cytoplasmic polyadenylation element-binding protein 1 isoform X2
cytoplasmic polyadenylation element-binding protein 1 isoform X1
cytoplasmic polyadenylation element-binding protein 1 isoform X4
cytoplasmic polyadenylation element-binding protein 1 isoform X5
adaptor related protein complex 3 subunit beta 2
nuclear receptor subfamily 2 group E member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 21 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
SUMO peptidase family member, NEDD8 specific, transcript variant X5
SUMO peptidase family member, NEDD8 specific, transcript variant X3
SUMO peptidase family member, NEDD8 specific, transcript variant X1
SUMO peptidase family member, NEDD8 specific, transcript variant X2
SUMO peptidase family member, NEDD8 specific, transcript variant X4
GRAM domain containing 2A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
GRAM domain containing 2A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
GRAM domain containing 2A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
GRAM domain containing 2A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
GRAM domain-containing protein 2A isoform X1
GRAM domain-containing protein 2A isoform X2
pyruvate kinase M1/2, transcript variant X2
pyruvate kinase M1/2, transcript variant X3
pyruvate kinase M1/2, transcript variant X1
poly(ADP-ribose) polymerase family member 6, transcript variant X2
poly(ADP-ribose) polymerase family member 6, transcript variant X3
poly(ADP-ribose) polymerase family member 6, transcript variant X4
poly(ADP-ribose) polymerase family member 6, transcript variant X5
poly(ADP-ribose) polymerase family member 6, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein mono-ADP-ribosyltransferase PARP6 isoform X2
protein mono-ADP-ribosyltransferase PARP6 isoform X3
protein mono-ADP-ribosyltransferase PARP6 isoform X4
protein mono-ADP-ribosyltransferase PARP6 isoform X5
poly(ADP-ribose) polymerase family member 6, transcript variant X1
protein mono-ADP-ribosyltransferase PARP6 isoform X1
CUGBP Elav-like family member 6, transcript variant X3
CUGBP Elav-like family member 6, transcript variant X2
CUGBP Elav-like family member 6, transcript variant X1
CUGBP Elav-like family member 6, transcript variant X4
CUGBP Elav-like family member 6, transcript variant X5
CUGBP Elav-like family member 6, transcript variant X6
CUGBP Elav-like family member 6 isoform X3
CUGBP Elav-like family member 6 isoform X2
CUGBP Elav-like family member 6 isoform X1
CUGBP Elav-like family member 6 isoform X5
CUGBP Elav-like family member 6 isoform X4
CUGBP Elav-like family member 6 isoform X6
ariadne RBR E3 ubiquitin protein ligase 1
Bardet-Biedl syndrome 4, transcript variant X2
Bardet-Biedl syndrome 4 protein isoform X2
Bardet-Biedl syndrome 4, transcript variant X1
Bardet-Biedl syndrome 4 protein isoform X1
Bardet-Biedl syndrome 4, transcript variant X3
Bardet-Biedl syndrome 4 protein isoform X3
ADP dependent glucokinase, transcript variant X2
ADP dependent glucokinase, transcript variant X1
ADP dependent glucokinase, transcript variant X3
uncharacterized LOC117001739, transcript variant X2
uncharacterized LOC117001739, transcript variant X1
uncharacterized LOC117001881, transcript variant X2
uncharacterized LOC117001881, transcript variant X3
uncharacterized LOC117001881, transcript variant X1
uncharacterized protein LOC117001881 isoform X1
uncharacterized protein LOC117001881 isoform X2
hyperpolarization activated cyclic nucleotide gated potassium channel 4
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
inhibitory synaptic factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
inhibitory synaptic factor 1, transcript variant X2
inhibitory synaptic factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
PML nuclear body scaffold, transcript variant X2
PML nuclear body scaffold, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
immunoglobulin superfamily containing leucine rich repeat 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
immunoglobulin superfamily containing leucine-rich repeat protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
immunoglobulin superfamily containing leucine-rich repeat protein 2
immunoglobulin superfamily containing leucine-rich repeat protein-like, transcript variant X3
immunoglobulin superfamily containing leucine-rich repeat protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
immunoglobulin superfamily containing leucine-rich repeat protein-like isoform X1
immunoglobulin superfamily containing leucine-rich repeat protein-like isoform X2
signaling receptor and transporter of retinol STRA6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
coiled-coil domain-containing protein 33
cholesterol side-chain cleavage enzyme, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
semaphorin 7A (John Milton Hagen blood group)
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
AT-rich interactive domain-containing protein 3B
CDC like kinase 3, transcript variant X1
CDC like kinase 3, transcript variant X2
enhancer of mRNA decapping 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
enhancer of mRNA decapping 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins
cytochrome P450 1A5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins
cytochrome P450 1A5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 9 ESTs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
unc-51 like kinase 3, transcript variant X1
unc-51 like kinase 3, transcript variant X2
serine/threonine-protein kinase ULK3 isoform X1
serine/threonine-protein kinase ULK3 isoform X2
unc-51 like kinase 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
unc-51 like kinase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
unc-51 like kinase 3, transcript variant X4
serine/threonine-protein kinase ULK3 isoform X3
secretory carrier-associated membrane protein 2
family with sequence similarity 219 member B
cytochrome c oxidase subunit 5A, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine beta-lactamase-like protein LACTB, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 44 ESTs, 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
C2 calcium-dependent domain-containing protein 4C-like
vacuolar protein sorting 13 homolog C, transcript variant X1
vacuolar protein sorting 13 homolog C, transcript variant X2
vacuolar protein sorting 13 homolog C, transcript variant X3
vacuolar protein sorting-associated protein 13C isoform X1
vacuolar protein sorting-associated protein 13C isoform X2
vacuolar protein sorting-associated protein 13C isoform X3
RAR related orphan receptor A, transcript variant X1
RAR related orphan receptor A, transcript variant X4
RAR related orphan receptor A, transcript variant X2
RAR related orphan receptor A, transcript variant X3
interactor of little elongation complex ELL subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
little elongation complex subunit 2 isoform X1
interactor of little elongation complex ELL subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
little elongation complex subunit 2 isoform X2
uncharacterized LOC117001819, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC117001819, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC117001819 isoform X2
uncharacterized protein LOC117001819 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
BCL2 interacting protein 2, transcript variant X1
BCL2 interacting protein 2, transcript variant X4
BCL2 interacting protein 2, transcript variant X5
BCL2 interacting protein 2, transcript variant X3
BCL2 interacting protein 2, transcript variant X2
BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 isoform X1
BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 isoform X3
BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 isoform X4
BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 isoform X2
general transcription factor IIA subunit 2
transcription initiation factor IIA subunit 2
glucosaminyl (N-acetyl) transferase 3, mucin type
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3
OTU deubiquitinase 7A, transcript variant X3
OTU deubiquitinase 7A, transcript variant X1
OTU deubiquitinase 7A, transcript variant X5
OTU deubiquitinase 7A, transcript variant X2
OTU deubiquitinase 7A, transcript variant X4
OTU domain-containing protein 7A isoform X1
OTU domain-containing protein 7A isoform X2
transient receptor potential cation channel subfamily M member 1
FANCD2 and FANCI associated nuclease 1, transcript variant X1
fanconi-associated nuclease 1 isoform X1
FANCD2 and FANCI associated nuclease 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
fanconi-associated nuclease 1 isoform X2
M-phase phosphoprotein 10, transcript variant X2
M-phase phosphoprotein 10, transcript variant X1
U3 small nucleolar ribonucleoprotein protein MPP10 isoform X2
U3 small nucleolar ribonucleoprotein protein MPP10 isoform X1
methylmalonyl-CoA epimerase, transcript variant X2
methylmalonyl-CoA epimerase, transcript variant X1
methylmalonyl-CoA epimerase, mitochondrial isoform X1
methylmalonyl-CoA epimerase, mitochondrial isoform X2
amyloid beta precursor protein binding family A member 2, transcript variant X2
amyloid beta precursor protein binding family A member 2, transcript variant X3
amyloid beta precursor protein binding family A member 2, transcript variant X1
amyloid-beta A4 precursor protein-binding family A member 2 isoform X1
amyloid-beta A4 precursor protein-binding family A member 2 isoform X2
family with sequence similarity 189 member A1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
family with sequence similarity 189 member A1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
family with sequence similarity 189 member A1, transcript variant X1
family with sequence similarity 189 member A1, transcript variant X6
family with sequence similarity 189 member A1, transcript variant X5
family with sequence similarity 189 member A1, transcript variant X7
family with sequence similarity 189 member A1, transcript variant X4
tight junction protein 1, transcript variant X2
tight junction protein 1, transcript variant X1
tight junction protein 1, transcript variant X3
tight junction protein 1, transcript variant X5
tight junction protein 1, transcript variant X4
threonine--tRNA ligase 2, cytoplasmic-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
LOW QUALITY PROTEIN: tight junction protein ZO-1-like
threonine--tRNA ligase 1, cytoplasmic-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 22 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
adenosine deaminase like, transcript variant X3
adenosine deaminase like, transcript variant X1
adenosine deaminase-like protein isoform X1
adenosine deaminase-like protein isoform X3
adenosine deaminase like, transcript variant X2
adenosine deaminase-like protein isoform X2
La ribonucleoprotein 6, translational regulator
leucine rich repeat containing 49, transcript variant X1
leucine-rich repeat-containing protein 49 isoform X1
leucine rich repeat containing 49, transcript variant X2
leucine-rich repeat-containing protein 49 isoform X2
thrombospondin type 1 domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
thrombospondin type 1 domain containing 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
thrombospondin type 1 domain containing 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
thrombospondin type 1 domain containing 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
thrombospondin type 1 domain containing 4, transcript variant X5
thrombospondin type-1 domain-containing protein 4 isoform X1
thrombospondin type 1 domain containing 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
thrombospondin type-1 domain-containing protein 4 isoform X2
cholinergic receptor nicotinic alpha 7 subunit
neuronal acetylcholine receptor subunit alpha-7
family with sequence similarity 81 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SAFB like transcription modulator, transcript variant X1
SAFB like transcription modulator, transcript variant X2
SAFB like transcription modulator, transcript variant X3
SAFB like transcription modulator, transcript variant X4
SAFB-like transcription modulator isoform X1
SAFB-like transcription modulator isoform X2
SAFB-like transcription modulator isoform X3
SAFB-like transcription modulator isoform X4
ubiquitin carboxyl-terminal hydrolase MINDY-2
disintegrin and metalloproteinase domain-containing protein 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
aldehyde dehydrogenase 1 family member A2
myocardial zonula adherens protein, transcript variant X3
myocardial zonula adherens protein isoform X3
myocardial zonula adherens protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
myocardial zonula adherens protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
myocardial zonula adherens protein isoform X2
myocardial zonula adherens protein isoform X1
transcription factor 12, transcript variant X2
transcription factor 12, transcript variant X4
transcription factor 12, transcript variant X3
transcription factor 12, transcript variant X8
transcription factor 12, transcript variant X5
transcription factor 12, transcript variant X6
transcription factor 12, transcript variant X9
transcription factor 12, transcript variant X7
transcription factor 12, transcript variant X1
transcription factor 12, transcript variant X13
transcription factor 12, transcript variant X14
transcription factor 12, transcript variant X12
transcription factor 12, transcript variant X10
transcription factor 12, transcript variant X11
zinc finger protein 280D, transcript variant X2
zinc finger protein 280D, transcript variant X1
zinc finger protein 280D, transcript variant X4
zinc finger protein 280D, transcript variant X5
zinc finger protein 280D, transcript variant X6
zinc finger protein 280D, transcript variant X3
LOW QUALITY PROTEIN: meiosis-specific nuclear structural protein 1
testis expressed 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
testis expressed 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
testis expressed 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
NEDD4 E3 ubiquitin protein ligase, transcript variant X5
E3 ubiquitin-protein ligase NEDD4 isoform X5
NEDD4 E3 ubiquitin protein ligase, transcript variant X1
NEDD4 E3 ubiquitin protein ligase, transcript variant X3
NEDD4 E3 ubiquitin protein ligase, transcript variant X2
NEDD4 E3 ubiquitin protein ligase, transcript variant X4
E3 ubiquitin-protein ligase NEDD4 isoform X1
E3 ubiquitin-protein ligase NEDD4 isoform X3
E3 ubiquitin-protein ligase NEDD4 isoform X2
E3 ubiquitin-protein ligase NEDD4 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
dynein axonemal assembly factor 4, transcript variant X2
dynein axonemal assembly factor 4 isoform X2
dynein axonemal assembly factor 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dynein axonemal assembly factor 4 isoform X4
dynein axonemal assembly factor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
dynein axonemal assembly factor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dynein axonemal assembly factor 4 isoform X1
dynein axonemal assembly factor 4 isoform X3
cell cycle progression 1, transcript variant X1
cell cycle progression 1, transcript variant X2
cell cycle progression protein 1 isoform X1
cell cycle progression protein 1 isoform X2
phosphatidylinositol glycan anchor biosynthesis class B
RAB27A, member RAS oncogene family, transcript variant X3
RAB27A, member RAS oncogene family, transcript variant X1
RAB27A, member RAS oncogene family, transcript variant X2
probable ribosome biogenesis protein RLP24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
family with sequence similarity 214 member A, transcript variant X1
family with sequence similarity 214 member A, transcript variant X2
cAMP regulated phosphoprotein 19, transcript variant X1
cAMP-regulated phosphoprotein 19 isoform X1
cAMP regulated phosphoprotein 19, transcript variant X2
cAMP-regulated phosphoprotein 19 isoform X2
guanine nucleotide-binding protein subunit beta-5
LEO1 homolog, Paf1/RNA polymerase II complex component, transcript variant X2
LEO1 homolog, Paf1/RNA polymerase II complex component, transcript variant X1
RNA polymerase-associated protein LEO1 isoform X2
RNA polymerase-associated protein LEO1 isoform X1
tropomodulin-3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 24 ESTs, 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
tropomodulin-3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 24 ESTs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
tropomodulin-3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 24 ESTs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tropomodulin-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 24 ESTs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
lysM and putative peptidoglycan-binding domain-containing protein 2
secretogranin III, transcript variant X2
secretogranin III, transcript variant X1
adaptor related protein complex 4 subunit epsilon 1, transcript variant X1
AP-4 complex subunit epsilon-1 isoform X1
adaptor related protein complex 4 subunit epsilon 1, transcript variant X2
AP-4 complex subunit epsilon-1 isoform X2
TNF alpha induced protein 8 like 3, transcript variant X1
TNF alpha induced protein 8 like 3, transcript variant X2
tumor necrosis factor alpha-induced protein 8-like protein 3 isoform X1
tumor necrosis factor alpha-induced protein 8-like protein 3 isoform X2
uncharacterized LOC117002127, transcript variant X1
uncharacterized LOC117002127, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 13 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
myelin expression factor 2, transcript variant X2
myelin expression factor 2, transcript variant X1
myelin expression factor 2, transcript variant X4
myelin expression factor 2, transcript variant X3
myelin expression factor 2, transcript variant X6
myelin expression factor 2, transcript variant X5
uncharacterized LOC117001940, transcript variant X1
uncharacterized LOC117001940, transcript variant X2
solute carrier family 12 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 12 member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 12 member 1 isoform X1
solute carrier family 12 member 1 isoform X2
deoxyuridine triphosphatase, transcript variant X1
deoxyuridine triphosphatase, transcript variant X2
deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial isoform X2
deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
SHC adaptor protein 4, transcript variant X1
SHC adaptor protein 4, transcript variant X2
selenocysteine insertion sequence-binding protein 2-like
COP9 signalosome subunit 2, transcript variant X2
COP9 signalosome subunit 2, transcript variant X1
COP9 signalosome complex subunit 2 isoform X2
COP9 signalosome complex subunit 2 isoform X1
fibroblast growth factor 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
fibroblast growth factor 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
fibroblast growth factor 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tRNA-uridine aminocarboxypropyltransferase 1
spermatogenesis-associated protein 5-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
normal mucosa of esophagus-specific gene 1 protein
biogenesis of lysosomal organelles complex 1 subunit 6
biogenesis of lysosome-related organelles complex 1 subunit 6
sulfide quinone oxidoreductase, transcript variant X1
sulfide quinone oxidoreductase, transcript variant X2
sulfide:quinone oxidoreductase, mitochondrial
CDC42 small effector protein 2-B-like, transcript variant X2
CDC42 small effector protein 2-B-like, transcript variant X1
signal peptide peptidase like 2A, transcript variant X1
signal peptide peptidase like 2A, transcript variant X2
signal peptide peptidase like 2A, transcript variant X4
signal peptide peptidase like 2A, transcript variant X3
signal peptide peptidase-like 2A isoform X1
signal peptide peptidase-like 2A isoform X3
signal peptide peptidase-like 2A isoform X2
signal peptide peptidase-like 2A isoform X4
transient receptor potential cation channel subfamily M member 7, transcript variant X2
transient receptor potential cation channel subfamily M member 7 isoform X2
transient receptor potential cation channel subfamily M member 7, transcript variant X1
transient receptor potential cation channel subfamily M member 7 isoform X1
transient receptor potential cation channel subfamily M member 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transient receptor potential cation channel subfamily M member 7 isoform X3
inactive ubiquitin carboxyl-terminal hydrolase 50
ubiquitin specific peptidase 8, transcript variant X2
ubiquitin specific peptidase 8, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 8 isoform X2
ubiquitin carboxyl-terminal hydrolase 8 isoform X1
GA binding protein transcription factor subunit beta 1, transcript variant X3
GA binding protein transcription factor subunit beta 1, transcript variant X2
GA binding protein transcription factor subunit beta 1, transcript variant X4
GA binding protein transcription factor subunit beta 1, transcript variant X5
GA binding protein transcription factor subunit beta 1, transcript variant X1
GA-binding protein subunit beta-1 isoform X1
GA-binding protein subunit beta-1 isoform X2
glycine amidinotransferase, transcript variant X2
glycine amidinotransferase, mitochondrial isoform X2
glycine amidinotransferase, transcript variant X1
glycine amidinotransferase, mitochondrial isoform X1
phosphodiesterase 8A, transcript variant X2
phosphodiesterase 8A, transcript variant X3
phosphodiesterase 8A, transcript variant X1
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X1
high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00426
fibronectin type III and SPRY domain containing 2
fibronectin type III and SPRY domain-containing protein 2
WASP homolog associated with actin, golgi membranes and microtubules
WASP homolog-associated protein with actin, membranes and microtubules
homer scaffold protein 2, transcript variant X6
homer scaffold protein 2, transcript variant X5
homer scaffold protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
homer scaffold protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
homer scaffold protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
homer scaffold protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
RNA guanine-7 methyltransferase activating subunit, transcript variant X1
RNA guanine-7 methyltransferase activating subunit, transcript variant X3
RNA guanine-7 methyltransferase activating subunit, transcript variant X2
RNA guanine-N7 methyltransferase activating subunit
transmembrane 6 superfamily member 1, transcript variant X1
transmembrane 6 superfamily member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
transmembrane 6 superfamily member 1 isoform X1
transmembrane 6 superfamily member 1 isoform X2
hepatoma-derived growth factor-related protein 3
uncharacterized LOC117001897, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC117001897, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein basonuclin-1 isoform X2
zinc finger protein basonuclin-1 isoform X1
SH3 domain containing GRB2 like 3, endophilin A3, transcript variant X2
SH3 domain containing GRB2 like 3, endophilin A3, transcript variant X1
lamin-L(III)-like, transcript variant X1
lamin-L(III)-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 34 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
lamin-L(III)-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 33 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 19 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
StAR related lipid transfer domain containing 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia- and flagella-associated protein 161-like
talin rod domain-containing protein 1-like
cell migration-inducing and hyaluronan-binding protein-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
LOW QUALITY PROTEIN: cilia- and flagella-associated protein 161-like
uncharacterized LOC117002163, transcript variant X2
uncharacterized LOC117002163, transcript variant X1
cell migration-inducing and hyaluronan-binding protein-like, transcript variant X2
cell migration-inducing and hyaluronan-binding protein-like, transcript variant X1
cell migration-inducing and hyaluronan-binding protein-like isoform X2
cell migration-inducing and hyaluronan-binding protein-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 42% coverage of the annotated genomic feature by RNAseq alignments
abhydrolase domain containing 17C, depalmitoylase
alpha/beta hydrolase domain-containing protein 17C
aryl hydrocarbon receptor nuclear translocator 2, transcript variant X3
aryl hydrocarbon receptor nuclear translocator 2, transcript variant X1
aryl hydrocarbon receptor nuclear translocator 2, transcript variant X2
aryl hydrocarbon receptor nuclear translocator 2 isoform X3
aryl hydrocarbon receptor nuclear translocator 2 isoform X1
aryl hydrocarbon receptor nuclear translocator 2 isoform X2
cortexin domain containing 1, transcript variant X2
cortexin domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 7 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
zinc finger AN1-type containing 6, transcript variant X3
zinc finger AN1-type containing 6, transcript variant X6
zinc finger AN1-type containing 6, transcript variant X2
zinc finger AN1-type containing 6, transcript variant X1
zinc finger AN1-type containing 6, transcript variant X5
zinc finger AN1-type containing 6, transcript variant X4
AN1-type zinc finger protein 6 isoform X2
AN1-type zinc finger protein 6 isoform X1
AN1-type zinc finger protein 6 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
membrane integral NOTCH2 associated receptor 1, transcript variant X1
membrane integral NOTCH2 associated receptor 1, transcript variant X3
membrane integral NOTCH2 associated receptor 1, transcript variant X4
membrane integral NOTCH2 associated receptor 1, transcript variant X2
major intrinsically disordered Notch2-binding receptor 1 isoform X1
membrane integral NOTCH2 associated receptor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
major intrinsically disordered Notch2-binding receptor 1 isoform X2
WD repeat domain 93, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat-containing protein 93 isoform X2
WD repeat domain 93, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WD repeat-containing protein 93 isoform X1
WD repeat domain 93, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
WD repeat-containing protein 93 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
ras-related and estrogen-regulated growth inhibitor-like protein
kinesin family member 7, transcript variant X1
kinesin family member 7, transcript variant X2
TOPBP1 interacting checkpoint and replication regulator
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 14 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117002051, transcript variant X2
uncharacterized LOC117002051, transcript variant X1
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
retinaldehyde binding protein 1, transcript variant X1
retinaldehyde binding protein 1, transcript variant X2
retinaldehyde-binding protein 1 isoform X1
retinaldehyde-binding protein 1 isoform X2
abhydrolase domain containing 2, acylglycerol lipase
milk fat globule EGF and factor V/VIII domain containing, transcript variant X1
milk fat globule EGF and factor V/VIII domain containing, transcript variant X2
hyaluronan and proteoglycan link protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hyaluronan and proteoglycan link protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
hyaluronan and proteoglycan link protein 3 isoform X1
hyaluronan and proteoglycan link protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
apoptosis enhancing nuclease, transcript variant X3
apoptosis enhancing nuclease, transcript variant X1
apoptosis enhancing nuclease, transcript variant X2
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X1
DET1 partner of COP1 E3 ubiquitin ligase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
28S ribosomal protein S11, mitochondrial
39S ribosomal protein L46, mitochondrial
neurotrophic receptor tyrosine kinase 3, transcript variant X1
neurotrophic receptor tyrosine kinase 3, transcript variant X2
neurotrophic receptor tyrosine kinase 3, transcript variant X3
AGBL carboxypeptidase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
AGBL carboxypeptidase 1, transcript variant X2
AGBL carboxypeptidase 1, transcript variant X1
AGBL carboxypeptidase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
A-kinase anchoring protein 13, transcript variant X12
A-kinase anchoring protein 13, transcript variant X3
A-kinase anchoring protein 13, transcript variant X9
A-kinase anchoring protein 13, transcript variant X5
A-kinase anchoring protein 13, transcript variant X6
A-kinase anchoring protein 13, transcript variant X11
A-kinase anchoring protein 13, transcript variant X10
A-kinase anchoring protein 13, transcript variant X8
A-kinase anchoring protein 13, transcript variant X2
A-kinase anchoring protein 13, transcript variant X7
A-kinase anchoring protein 13, transcript variant X4
A-kinase anchoring protein 13, transcript variant X1
A-kinase anchoring protein 13, transcript variant X13
A-kinase anchoring protein 13, transcript variant X15
A-kinase anchoring protein 13, transcript variant X16
A-kinase anchoring protein 13, transcript variant X17
A-kinase anchoring protein 13, transcript variant X14
A-kinase anchoring protein 13, transcript variant X18
synaptic vesicle glycoprotein 2B, transcript variant X3
synaptic vesicle glycoprotein 2B, transcript variant X1
synaptic vesicle glycoprotein 2B, transcript variant X4
synaptic vesicle glycoprotein 2B, transcript variant X2
solute carrier organic anion transporter family member 3A1
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
family with sequence similarity 174 member B
chromodomain helicase DNA binding protein 2, transcript variant X2
chromodomain helicase DNA binding protein 2, transcript variant X1
chromodomain helicase DNA binding protein 2, transcript variant X3
chromodomain helicase DNA binding protein 2, transcript variant X5
chromodomain helicase DNA binding protein 2, transcript variant X4
chromodomain-helicase-DNA-binding protein 2
repulsive guidance molecule BMP co-receptor a
multiple C2 and transmembrane domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 2 isoform X1
multiple C2 and transmembrane domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
multiple C2 and transmembrane domain-containing protein 2 isoform X2
uncharacterized LOC117001858, transcript variant X2
uncharacterized LOC117001858, transcript variant X6
uncharacterized LOC117001858, transcript variant X14
uncharacterized LOC117001858, transcript variant X12
uncharacterized LOC117001858, transcript variant X21
uncharacterized LOC117001858, transcript variant X24
uncharacterized LOC117001858, transcript variant X18
uncharacterized LOC117001858, transcript variant X22
uncharacterized LOC117001858, transcript variant X17
uncharacterized LOC117001858, transcript variant X15
uncharacterized LOC117001858, transcript variant X25
uncharacterized LOC117001858, transcript variant X23
uncharacterized LOC117001858, transcript variant X5
uncharacterized LOC117001858, transcript variant X20
uncharacterized LOC117001858, transcript variant X19
uncharacterized LOC117001858, transcript variant X11
uncharacterized LOC117001858, transcript variant X13
uncharacterized LOC117001858, transcript variant X9
uncharacterized LOC117001858, transcript variant X8
uncharacterized LOC117001858, transcript variant X10
uncharacterized LOC117001858, transcript variant X16
uncharacterized LOC117001858, transcript variant X7
uncharacterized LOC117001858, transcript variant X3
uncharacterized LOC117001858, transcript variant X4
uncharacterized LOC117001858, transcript variant X1
nuclear receptor subfamily 2 group F member 2, transcript variant X4
nuclear receptor subfamily 2 group F member 2, transcript variant X3
nuclear receptor subfamily 2 group F member 2, transcript variant X2
nuclear receptor subfamily 2 group F member 2, transcript variant X1
uncharacterized LOC117002110, transcript variant X2
uncharacterized LOC117002110, transcript variant X3
uncharacterized LOC117002110, transcript variant X1
uncharacterized LOC117002155, transcript variant X2
uncharacterized LOC117002155, transcript variant X1
uncharacterized LOC117002155, transcript variant X4
uncharacterized LOC117002155, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
insulin like growth factor 1 receptor, transcript variant X2
insulin like growth factor 1 receptor, transcript variant X1
insulin-like growth factor 1 receptor isoform X2
insulin-like growth factor 1 receptor isoform X1
leucine rich repeat containing 28, transcript variant X1
leucine rich repeat containing 28, transcript variant X2
leucine-rich repeat-containing protein 28 isoform X1
leucine rich repeat containing 28, transcript variant X5
leucine rich repeat containing 28, transcript variant X3
leucine rich repeat containing 28, transcript variant X4
leucine-rich repeat-containing protein 28 isoform X2
myocyte enhancer factor 2A, transcript variant X5
myocyte enhancer factor 2A, transcript variant X1
myocyte enhancer factor 2A, transcript variant X3
myocyte enhancer factor 2A, transcript variant X2
myocyte enhancer factor 2A, transcript variant X4
myocyte-specific enhancer factor 2A isoform X5
myocyte-specific enhancer factor 2A isoform X2
myocyte-specific enhancer factor 2A isoform X4
myocyte-specific enhancer factor 2A isoform X1
myocyte-specific enhancer factor 2A isoform X3
LysM domain containing 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
LysM domain containing 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
LysM domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
lysM and putative peptidoglycan-binding domain-containing protein 4
ADAM metallopeptidase with thrombospondin type 1 motif 17
A disintegrin and metalloproteinase with thrombospondin motifs 17
ceramide synthase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ceramide synthase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ceramide synthase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ceramide synthase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ankyrin repeat and SOCS box containing 7
aldehyde dehydrogenase 1 family member A3
aldehyde dehydrogenase family 1 member A3
leucine rich repeat kinase 1, transcript variant X1
leucine rich repeat kinase 1, transcript variant X2
leucine-rich repeat serine/threonine-protein kinase 1 isoform X1
leucine-rich repeat serine/threonine-protein kinase 1 isoform X2
leucine rich repeat kinase 1, transcript variant X3
leucine rich repeat kinase 1, transcript variant X4
leucine-rich repeat serine/threonine-protein kinase 1 isoform X3
small nuclear ribonucleoprotein polypeptide A'
proprotein convertase subtilisin/kexin type 6
pleckstrin homology domain containing O2
pleckstrin homology domain-containing family O member 2
ankyrin repeat and death domain containing 1A, transcript variant X1
ankyrin repeat and death domain-containing protein 1A isoform X1
ankyrin repeat and death domain containing 1A, transcript variant X2
ankyrin repeat and death domain-containing protein 1A isoform X2
SPG21 abhydrolase domain containing, maspardin, transcript variant X1
SPG21 abhydrolase domain containing, maspardin, transcript variant X2
caseinolytic mitochondrial matrix peptidase chaperone subunit X, transcript variant X1
caseinolytic mitochondrial matrix peptidase chaperone subunit X, transcript variant X2
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial isoform X1
ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial isoform X2
programmed cell death 7, transcript variant X2
programmed cell death 7, transcript variant X1
ubiquitin associated protein 1 like, transcript variant X2
ubiquitin associated protein 1 like, transcript variant X3
ubiquitin associated protein 1 like, transcript variant X1
ubiquitin-associated protein 1-like isoform X1
ubiquitin-associated protein 1-like isoform X2
RAS like family 12, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
kelch repeat and BTB domain containing 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
kelch repeat and BTB domain-containing protein 13
RAS like family 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
RAS like family 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
RAS like family 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ras-like protein family member 12 isoform X1
ras-like protein family member 12 isoform X2
mitochondrial methionyl-tRNA formyltransferase
methionyl-tRNA formyltransferase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
gonadotropin-releasing hormone II receptor-like, transcript variant X1
gonadotropin-releasing hormone II receptor-like, transcript variant X2
gonadotropin-releasing hormone II receptor-like, transcript variant X3
gonadotropin-releasing hormone II receptor-like
poly(ADP-ribose) polymerase family member 16
protein mono-ADP-ribosyltransferase PARP16
immunoglobulin superfamily DCC subclass member 3, transcript variant X2
immunoglobulin superfamily DCC subclass member 3, transcript variant X1
immunoglobulin superfamily DCC subclass member 3 isoform X1
immunoglobulin superfamily DCC subclass member 3 isoform X2
immunoglobulin superfamily DCC subclass member 4, transcript variant X2
immunoglobulin superfamily DCC subclass member 4, transcript variant X1
immunoglobulin superfamily DCC subclass member 4 isoform X2
immunoglobulin superfamily DCC subclass member 4 isoform X1
dipeptidyl peptidase 8, transcript variant X1
dipeptidyl peptidase 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
dipeptidyl peptidase 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase
sodium/potassium/calcium exchanger 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
C-myc promoter-binding protein-like, transcript variant X2
C-myc promoter-binding protein-like, transcript variant X3
C-myc promoter-binding protein-like, transcript variant X4
C-myc promoter-binding protein-like, transcript variant X1
C-myc promoter-binding protein-like isoform X2
C-myc promoter-binding protein-like isoform X1
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
multiple epidermal growth factor-like domains protein 11, transcript variant X2
multiple epidermal growth factor-like domains protein 11, transcript variant X1
multiple epidermal growth factor-like domains protein 11 isoform X2
multiple epidermal growth factor-like domains protein 11 isoform X1
immunoglobulin superfamily DCC subclass member 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
immunoglobulin superfamily DCC subclass member 4-like, transcript variant X3
immunoglobulin superfamily DCC subclass member 4-like, transcript variant X2
immunoglobulin superfamily DCC subclass member 4-like, transcript variant X1
immunoglobulin superfamily DCC subclass member 4-like isoform X2
immunoglobulin superfamily DCC subclass member 4-like isoform X1
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
DENN domain containing 4A, transcript variant X2
DENN domain containing 4A, transcript variant X3
DENN domain containing 4A, transcript variant X1
C-myc promoter-binding protein isoform X2
C-myc promoter-binding protein isoform X1
multiple EGF like domains 11, transcript variant X5
multiple EGF like domains 11, transcript variant X8
multiple EGF like domains 11, transcript variant X3
multiple EGF like domains 11, transcript variant X10
multiple EGF like domains 11, transcript variant X7
multiple EGF like domains 11, transcript variant X4
multiple EGF like domains 11, transcript variant X1
multiple EGF like domains 11, transcript variant X2
multiple epidermal growth factor-like domains protein 11 isoform X4
multiple epidermal growth factor-like domains protein 11 isoform X7
multiple epidermal growth factor-like domains protein 11 isoform X9
multiple epidermal growth factor-like domains protein 11 isoform X6
multiple epidermal growth factor-like domains protein 11 isoform X3
multiple EGF like domains 11, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
multiple EGF like domains 11, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
multiple epidermal growth factor-like domains protein 11 isoform X8
multiple epidermal growth factor-like domains protein 11 isoform X5
multiple EGF like domains 11, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
multiple epidermal growth factor-like domains protein 11 isoform X10
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
DIS3 like exosome 3'-5' exoribonuclease, transcript variant X2
TIMELESS interacting protein, transcript variant X3
TIMELESS interacting protein, transcript variant X2
TIMELESS interacting protein, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00582
mitogen-activated protein kinase kinase 1
dual specificity mitogen-activated protein kinase kinase 1
small nuclear RNA activating complex polypeptide 5
snRNA-activating protein complex subunit 5
COORDINATES: nucleotide motif:Rfam:12.0:RF00093
COORDINATES: nucleotide motif:Rfam:12.0:RF00138
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
mothers against decapentaplegic homolog 6
SMAD family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SMAD family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mothers against decapentaplegic homolog 3 isoform X1
mothers against decapentaplegic homolog 3 isoform X2
alpha- and gamma-adaptin-binding protein p34
IQ motif containing H, transcript variant X1
IQ motif containing H, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
IQ domain-containing protein H isoform X2
IQ domain-containing protein H isoform X1
uncharacterized protein C15orf61 homolog
mitogen-activated protein kinase kinase 5, transcript variant X1
mitogen-activated protein kinase kinase 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
dual specificity mitogen-activated protein kinase kinase 5 isoform X1
dual specificity mitogen-activated protein kinase kinase 5 isoform X2
SKI family transcriptional corepressor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 10 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
calmodulin like 4, transcript variant X2
calmodulin like 4, transcript variant X1
calmodulin like 4, transcript variant X3
ceroid-lipofuscinosis neuronal protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
acidic nuclear phosphoprotein 32 family member A, transcript variant X2
acidic nuclear phosphoprotein 32 family member A, transcript variant X1
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X2
acidic leucine-rich nuclear phosphoprotein 32 family member A isoform X1
uncharacterized LOC117002126, transcript variant X1
uncharacterized LOC117002126, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
progestin and adipoQ receptor family member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
progestin and adipoQ receptor family member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
progestin and adipoQ receptor family member 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
progestin and adipoQ receptor family member 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
progestin and adipoQ receptor family member 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
progestin and adipoQ receptor family member 5, transcript variant X3
TLE family member 3, transcriptional corepressor, transcript variant X7
TLE family member 3, transcriptional corepressor, transcript variant X5
TLE family member 3, transcriptional corepressor, transcript variant X6
TLE family member 3, transcriptional corepressor, transcript variant X4
TLE family member 3, transcriptional corepressor, transcript variant X2
TLE family member 3, transcriptional corepressor, transcript variant X3
TLE family member 3, transcriptional corepressor, transcript variant X1
transducin-like enhancer protein 3 isoform X7
transducin-like enhancer protein 3 isoform X5
transducin-like enhancer protein 3 isoform X6
transducin-like enhancer protein 3 isoform X4
transducin-like enhancer protein 3 isoform X2
transducin-like enhancer protein 3 isoform X3
transducin-like enhancer protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uveal autoantigen with coiled-coil domains and ankyrin repeats, transcript variant X1
uveal autoantigen with coiled-coil domains and ankyrin repeats, transcript variant X2
uveal autoantigen with coiled-coil domains and ankyrin repeats isoform X1
uveal autoantigen with coiled-coil domains and ankyrin repeats isoform X2
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ADAM metallopeptidase with thrombospondin type 1 motif 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 7
cytosolic iron-sulfur assembly component 2A
SPG11 vesicle trafficking associated, spatacsin, transcript variant X1
SPG11 vesicle trafficking associated, spatacsin, transcript variant X2
eukaryotic translation initiation factor 3 subunit J
golgi membrane protein 2, transcript variant X4
golgi membrane protein 2, transcript variant X2
golgi membrane protein 2, transcript variant X3
golgi membrane protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
BLM RecQ like helicase, transcript variant X1
BLM RecQ like helicase, transcript variant X2
Ras protein specific guanine nucleotide releasing factor 1
ras-specific guanine nucleotide-releasing factor 1
ankyrin repeat domain 34C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ankyrin repeat domain 34C, transcript variant X2
ankyrin repeat domain-containing protein 34C
transmembrane emp24 domain-containing protein 3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transmembrane emp24 domain-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adaptor related protein complex 3 subunit sigma 2
zinc finger protein 710, transcript variant X2
zinc finger protein 710, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 97% coverage of the annotated genomic feature by RNAseq alignments
isocitrate dehydrogenase (NADP(+)) 2, transcript variant X2
isocitrate dehydrogenase (NADP(+)) 2, transcript variant X1
isocitrate dehydrogenase [NADP], mitochondrial isoform X1
isocitrate dehydrogenase [NADP], mitochondrial isoform X2
GDP-D-glucose phosphorylase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
GDP-D-glucose phosphorylase 1, transcript variant X1
neugrin, neurite outgrowth associated, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
neugrin, neurite outgrowth associated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
neugrin, neurite outgrowth associated, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1
VPS33B late endosome and lysosome associated, transcript variant X1
VPS33B late endosome and lysosome associated, transcript variant X2
vacuolar protein sorting-associated protein 33B isoform X1
vacuolar protein sorting-associated protein 33B isoform X2
protein regulator of cytokinesis 1, transcript variant X2
protein regulator of cytokinesis 1, transcript variant X1
protein regulator of cytokinesis 1, transcript variant X3
protein regulator of cytokinesis 1 isoform X1
protein regulator of cytokinesis 1 isoform X2
protein regulator of cytokinesis 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mannosidase alpha class 2A member 2, transcript variant X1
mannosidase alpha class 2A member 2, transcript variant X2
FES proto-oncogene, tyrosine kinase, transcript variant X5
FES proto-oncogene, tyrosine kinase, transcript variant X3
FES proto-oncogene, tyrosine kinase, transcript variant X2
FES proto-oncogene, tyrosine kinase, transcript variant X1
tyrosine-protein kinase Fes/Fps isoform X4
tyrosine-protein kinase Fes/Fps isoform X3
tyrosine-protein kinase Fes/Fps isoform X2
tyrosine-protein kinase Fes/Fps isoform X1
FES proto-oncogene, tyrosine kinase, transcript variant X4
furin, paired basic amino acid cleaving enzyme, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 4 ESTs, 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
furin, paired basic amino acid cleaving enzyme, transcript variant X2
furin, paired basic amino acid cleaving enzyme, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 4 ESTs, 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP8-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
LOW QUALITY PROTEIN: peptidyl-prolyl cis-trans isomerase FKBP8-like
protein disulfide isomerase family A member 3
diphosphoinositol pentakisphosphate kinase 1, transcript variant X2
diphosphoinositol pentakisphosphate kinase 1, transcript variant X1
diphosphoinositol pentakisphosphate kinase 1, transcript variant X4
diphosphoinositol pentakisphosphate kinase 1, transcript variant X5
diphosphoinositol pentakisphosphate kinase 1, transcript variant X6
diphosphoinositol pentakisphosphate kinase 1, transcript variant X3
diphosphoinositol pentakisphosphate kinase 1, transcript variant X7
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 isoform X1
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 isoform X3
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 isoform X4
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 isoform X5
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 isoform X2
inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 isoform X6
microtubule associated protein 1A, transcript variant X1
microtubule associated protein 1A, transcript variant X2
microtubule associated protein 1A, transcript variant X3
microtubule-associated protein 1A isoform X1
microtubule-associated protein 1A isoform X2
microtubule-associated protein 1A isoform X3
tumor protein p53 binding protein 1, transcript variant X5
tumor protein p53 binding protein 1, transcript variant X1
tumor protein p53 binding protein 1, transcript variant X3
tumor protein p53 binding protein 1, transcript variant X2
tumor protein p53 binding protein 1, transcript variant X4
tubulin gamma complex associated protein 4, transcript variant X2
tubulin gamma complex associated protein 4, transcript variant X1
tubulin gamma complex associated protein 4, transcript variant X3
gamma-tubulin complex component 4 isoform X2
gamma-tubulin complex component 4 isoform X1
gamma-tubulin complex component 4 isoform X3
uncharacterized LOC117001877, transcript variant X1
uncharacterized LOC117001877, transcript variant X2